Patient P-03108
Therapy response
Unstable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
23%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S19
- Day 96 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 96.
Primary contributors, last 14 days
- Inflammatory activity+6
- Treatment adherence-6
- GI instability+3
- Toxicity-3
- Nutritional resilience-2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log5.5/10
worsening · -0.8 vs previous 14 d
Stress level
Daily log4.1/10
worsening · +0.6 vs previous 14 d
Pessimism score
Daily log4.4/10
worsening · +0.7 vs previous 14 d
Sleep quality
Wearable33/100
stable · -1.2 vs previous 14 d
Libido
Daily log4.9/10
worsening · -0.7 vs previous 14 d
HRV
Wearable34.6 ms
worsening · -2.6 vs previous 14 d
Toxicity
Blood18/100
worsening · +6.6 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 66 from the failing basin, 46 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -5.6 next day on high-intake days · n 22
Would not help
- AD-05 Adherence Supportonly 29% improved among 14 similar
- Keep histamine lowGI +5.4 next day on high-intake days · n 22
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-5.6supporter · 95%
- Histamine load+5.4detractor · 95%
- Dietary fat load+1.9no signal · 40%
- Alcohol-1.4no signal · 29%
- Lactose+1.1no signal · 25%
- Caffeine0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↑65
- WearableResting HR 75 bpm
- Wearable3,972 steps/day
- WearableShort sleep window
- Mucosal barrier integrity ↓60
- DNAFUT2 non-secretor lowers mucosal fucosylation
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↑15
- WearableHRV 35 ms, trending down
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Rapid metabolizerExpected exposure
Microbiome
Shannon diversity 4.3 · butyrate capacity 66/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 31 ms
- Sleep
- 6.7 h
- Steps
- 3,750
- Resting HR
- 73 bpm
Daily log: GI score 18, nutritional resilience 69, adherence 74.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.